Back to search
FDAFDA · Food and drugs·Recall number D-1215-2015

Enalapril maleate and hydrochlorothiazide tablets USP, 10/25 mg, 100-count bottle, Rx only, Manufactured for Apotex Inc 150 Signet Drive, ON M9L1T9 by Apotex Research Private Limited, Plot 1 & 2, Bommasandra Industrial Area, 4th Phase Jigani Link Road, Bangalore, Karnataka, 560099, India, NDC 60505-0209-1

Published July 15, 2015 · Recall initiated: May 29, 2015

Summary

FDA records drug Class II recall D-1215-2015, published July 15, 2015 and initiated May 29, 2015. Recalling firm: Apotex Inc.; Status: Terminated; Reported quantity: 4,584 bottles; Lot: Lot #: KP4529, Exp 10/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Apotex Inc.
Distributor
Nationwide, Hawaii and Puerto Rico
Lot
Lot #: KP4529, Exp 10/2015
Risk classification
Class II
Area (FDA)
drug
Country
Canada

Related recalls

Questions about this recall

Was Enalapril maleate and hydrochlorothiazide tablets USP, 10/25 mg, 100-count bottle, Rx only, Manufactured for Apotex Inc 150 Signet Drive, ON M9L1T9 by Apotex Research Private Limited, Plot 1 & 2, Bommasandra Industrial Area, 4th Phase Jigani Link Road, Bangalore, Karnataka, 560099, India, NDC 60505-0209-1 recalled?

Yes. FDA published recall D-1215-2015 on July 15, 2015. Reported hazard: Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.

What should I do if I have this product?

Voluntary: Firm initiated · Letter